Manulife (Manufacturers Life Insurance)
ORIC icon

Manulife (Manufacturers Life Insurance)’s Oric Pharmaceuticals ORIC Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.31M Buy
182,139
+53,490
+42% +$607K ﹤0.01% 1441
2025
Q4 		$1.04M Buy
128,649
+1,985
+2% +$22.8K ﹤0.01% 1833
2025
Q3 		$1.52M Buy
126,664
+2,556
+2% +$26.9K ﹤0.01% 1638
2025
Q2 		$1.26M Sell
124,108
-5,549
-4% -$37.3K ﹤0.01% 1714
2025
Q1 		$723K Sell
129,657
-531
-0.4% -$4.64K ﹤0.01% 1958
2024
Q4 		$1.05M Sell
130,188
-452
-0.3% -$4.15K ﹤0.01% 1888
2024
Q3 		$1.34M Sell
130,640
-710
-0.5% -$7.02K ﹤0.01% 1766
2024
Q2 		$929K Buy
131,350
+9,424
+8% +$84.4K ﹤0.01% 1900
2024
Q1 		$1.68M Buy
121,926
+74,095
+155% +$880K ﹤0.01% 1579
2023
Q4 		$440K Buy
47,831
+31,448
+192% +$227K ﹤0.01% 2229
2023
Q3 		$99.1K Hold
16,383
– – ﹤0.01% 2811
2023
Q2 		$127K Buy
+16,383
New +$93.1K ﹤0.01% 2760
2022
Q2 		– Sell
-14,105
Closed -$75.3K – 3099
2022
Q1 		$75.3K Sell
14,105
-2,856
-17% -$25.7K ﹤0.01% 3001
2021
Q4 		$249 Buy
16,961
+798
+5% +$12.4K ﹤0.01% 2754
2021
Q3 		$338K Sell
16,163
-855
-5% -$17.3K ﹤0.01% 2574
2021
Q2 		$301K Buy
17,018
+4,140
+32% +$90.7K ﹤0.01% 2809
2021
Q1 		$316K Sell
12,878
-29
-0.2% -$916 ﹤0.01% 2582
2020
Q4 		$437K Buy
+12,907
New +$370K ﹤0.01% 2281

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ORIC Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Oric Pharmaceuticals (ORIC) stake by 42% in Q1 2026, buying an estimated $607K and bringing the position to 182,139 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1441.

Manulife (Manufacturers Life Insurance) first reported a position in ORIC in Q4 2020 and has held it in 18 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 182,139 shares of Oric Pharmaceuticals worth $2.31M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 53,490 Oric Pharmaceuticals shares in Q1 2026, an estimated $607K.
  • Oric Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1441 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Oric Pharmaceuticals in Q4 2020 and has held it in 18 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.